Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
* Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count >= ,/ul (transfusion independent, defined as not receiving platelet transfusions within a  day period prior to enrollment)
Platelet count >= ,/uL (transfusion independent, defined as not receiving platelet transfusions within  days prior to enrollment) for subjects without bone marrow involvement
Screening platelet count should be independent of platelet transfusions for at least  weeks.
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count ??/L, with no platelet transfusions within the prior  days.
Platelet count of at least ,/L (transfusion independent, defined as not receiving platelet transfusions within a -day period prior to enrollment)
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment).
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count ?  ^/L (not receiving platelet transfusions within a -day period prior to study drug administration).
Platelet count >= ,/mm^ (transfusion independent defined as not receiving platelet transfusions within a  day period prior to enrollment)
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment) within  days of registration
Platelet count >= ,/ mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count of >= ,/uL (transfusion independent, defined as not receiving platelet transfusions within  days prior to laboratory sample)
PART  GROUP  INCLUSION CRITERIA: Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
PART  GROUP  INCLUSION CRITERIA: Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count >= ,/uL; platelet transfusions are not allowed within  days of platelet assessment
Platelet count ,/uL (transfusion independent, defined as not receiving platelet transfusions within a  day period prior to enrollment. Exception: Patients that are platelet dependent due to previous extensive treatment- e.g. - MIBG therapy).
Screening platelet count should be independent of platelet transfusions for at least  week
Platelet count ?  ^/L (transfusion independent, defined as not receiving platelet transfusions within a -day period prior to study drug administration)
Platelet count >= , mm^; platelet count should be independent of transfusions for at least  days for eligibility
Platelet count: >= ,/ul, transfusion independent (no platelet transfusions within  week)
Platelet count > ,/mm^. Patients who have bone marrow infiltration by MCL are eligible if their platelet level is >= , /mm^ independent of platelet transfusions.
Within  days prior to study registration: Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions within a  day period prior to enrollment); in NB patients with known bone marrow involvement relaxed platelet count eligibility requirement should be used: a platelet count of >= ,/mm that can be maintained with =<  platelet transfusion per week
Platelet count: >= ,/mm^, transfusion independent (no platelet transfusions within  week)
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count ?/L and no platelet transfusions during the prior  days
Platelet count >= ,/mm^; platelet transfusions are not allowed within  days before study enrollment
Platelet count >= ,/mm^ (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment) and
Platelet count >=  x ^/L; screening platelet count should be independent of platelet transfusions for at least  weeks
Platelet count >= ,/uL (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Platelet count >= ,/uL (transfusion independent, defined as not receiving platelet transfusions for at least  days prior to enrollment)
Screening platelet count should be independent of platelet transfusions for at least  weeks
Screening platelet count >=  x ^/L independent of platelet transfusions for at least  weeks
Platelet count: ,/ul and transfusion independent (no platelet transfusions within  days of blood draw documenting eligibility)
Platelet count >=  x ^/L (platelet transfusions cannot be used within  days of first drug administration)
Subject has a platelet count of less than , mm within  days prior to randomization (platelet transfusions are allowed)
